Navigation Links
Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk
Date:7/8/2008

Could improve current assessments, report says

TUESDAY, July 8 (HealthDay News) -- A seldom-used test that measures blood pressure in the ankle and the arm can help improve assessment of the risk of heart disease, stroke and other cardiovascular problems, an international research group reports.

It has a distinct advantage in that it is extremely easy to perform and doesn't require expensive, sophisticated equipment, Gerry Fowkes, a professor of epidemiology at the University of Edinburgh, Scotland, said of the ankle brachial index (ABI). The device is the subject of a report in the July 9 issue of the Journal of the American Medical Association. The index is the ratio between the blood pressure measurements in the ankle and the arm.

The ABI should be used to supplement rather than replace standard measures of cardiovascular risk such as cholesterol, blood pressure, obesity and physical activity, Fowkes said.

"It has been shown that using these common risk factors, prediction is not as good as it might be," he said. "That is why we and others have been looking for other factors to improve prediction."

The meta-analysis used data from 16 studies around the world, including 24,955 men and 23,339 women who were followed after an initial ABI measurement. Over the next 10 years, 4.4 percent of men with a normal ABI died, compared to 18.7 percent of men with an abnormally low ABI. Death rates for women were 12.6 percent for those with a low ABI, 4.1 percent for those with a normal ABI.

A lower ABI was associated with approximately a doubled risk of death from any cause, cardiovascular death, and a major coronary event over the 10 years, the report said. Including the ABI in current risk factor assessments would mean reclassification of cardiovascular risk and change of the measures taken to prevent cardiovascular events for 19 percent of men and 36 percent of women, the researchers estimated.

Studies about the use of the ABI are continuing, Fowkes said. "The next step is to look at the prediction made by combining the ABI and other risk factors," he said. "Any individual who is having a cardiovascular risk assessment would benefit from having this test, but when we have done further work in looking at the detailed accuracy of the prediction, proper use of the test will become more obvious."

ABI testing right now isn't for everyone, said Dr. Aaron B. Folsom, a professor of epidemiology at the University of Minnesota, and a member of the research team.

It is being promoted as a way of measuring the risk of peripheral arterial disease (PAD), blockage of blood vessels in the legs, and so it is best used for older people, who are at greater risk of PAD, Folsom said. Wider use can be proposed, because "the more information you have, the better you do in classifying cardiovascular risk," Folsom said.

A low ABI reading would mean greater emphasis for that individual on the classic risk factors -- blood cholesterol, blood pressure, diabetes, obesity and the others, Folsom added. "We do have interventions that we know work, such as glucose-lowering and physical activity," he said.

More information

Learn how the ABI is determined and what it means from the Vascular Disease Foundation.



SOURCES: Gerry Fowkes, Ph.D., professor, epidemiology, University of Edinburgh, Scotland; Aaron B. Folsom, M.D., professor, epidemiology, University of Minnesota, Minneapolis; July 9, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fish oil and red yeast rice studied for lowering blood cholesterol
2. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
3. Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure
4. Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Womens Menstrual Blood
5. FDA Grants AMDL Clearance to Market the AMDL-ELISA DR-70(R) (FDP) Blood Test for Monitoring Colorectal Cancer
6. Working Hard When Tired Raises Blood Pressure
7. Blood vessel inhibitor shows promise against metastatic thyroid cancer
8. Hibernation-on-demand drug significantly improves survival after extreme blood loss
9. Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch, New Endurance Products SR L-Arginine and Grape Seed Extract
10. Scientists find how neural activity spurs blood flow in the brain
11. Umbilical cord blood cell transplants may help ALS patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
Breaking Medicine Technology: